Articles

Latest news and updates about the Medicare and pharmacy industries.

April 26: FDA Approves First Generic Naloxone Nasal Spray, Medicare and Social Security Are On Shaky Ground, And More

Posted on in Industry Updates by Amplicare Team

Here’s the latest in the world of pharmacy and healthcare:

1. The FDA has approved the first generic naloxone nasal spray for use by individuals without medical training. Commonly known as Narcan, the medication is used to stop or reverse the effects of opioid overdoses and is an essential part of the efforts to combat the opioid crisis. The agency also announced plans to prioritize reviews of generic drug applications for products used to treat opioid overdose. Read more from FDA.gov.

2. Medicare and Social Security are on shaky ground. According to a report released this week, the financial future of the retirement programs is uncertain with Medicare projected to become insolvent by 2026 and Social Security by 2035. Running out of funds means the programs would be unable to cover the cost of promised benefits and could lead to benefit cuts for retirees or fee cuts for hospitals, nursing homes, and other medical providers. Read more from AP.

3. A majority of Americans want to keep the Affordable Care Act’s (ACA) protections for pre-existing medical conditions, says a new Kaiser Family Foundation poll. Of those surveyed, 68% say they don’t want to see the Supreme Court overturn the protection while another 54% say the same about the entire ACA law. The results also showed that a greater number of Americans believe targeted actions on issues like prescription drug costs are a higher priority for Congress than broader reforms. Read more from KFF Health.

4. The U.S. Department of Health and Human Services has extended the deadline to weigh in on two proposed regulations to support the secure access, exchange, and use of electronic health information. Stakeholders now have until June 3 to submit comments on the rules, which promote the interoperability of health information technology and enable patients to electronically access their health information. Read more from HHS.gov.

5. The CMS’ new Primary Cares Initiative is overhauling primary care payment models by providing incentives for positive patient experiences. The agency recently introduced five voluntary payment models for providers, aimed at improving patient care access, patient experiences, and chronic disease management. The first of the models, targeted to smaller practices, will launch in January 2020 and be tested for five years. Read more from Patient Engagement HIT.

Other Articles

Posted on by Amplicare Team

July 12: Novartis Epinephrine Shots Will Soon Be Available in U.S. Pharmacies

Amid a shortage of EpiPens, Novartis is extending the availability of its generic pre-filled epinephrine shots to pharmacies across...
Continue Reading

Posted on by Amplicare Team

Medicare Advantage: What’s Changed for 2020

Earlier this year, CMS released updates to Medicare Advantage and Part D programs for the upcoming plan year. As...
Continue Reading

Posted on by Amplicare Team

June 28: A New Bill Aims to Increase Access to Vaccinations

A bipartisan bill could help provide shingles and Tdap vaccinations to Medicare beneficiaries at no extra cost, and more...
Continue Reading

Posted on by Amplicare Team

What to Consider When Talking to Patients About Naloxone

Despite the known benefits of naloxone, approaching the conversation about its necessity with patients is not always easy for...
Continue Reading